Mr. David F. Carroll, also known as Dave, M.B.A. has been Chief Financial Officer and Treasurer at Ophthotech Corporation since April 24, 2017 and served as its Senior Vice President of Finance. Mr. Carroll joined Ophthotech in June 2016 and served as Senior Vice President of Finance from June 2016 to April 2017. Mr. Carroll served in several senior financial leadership roles at The Medicines Company from May 2008 to June 2016, including Vice President and Controller from October 2008 to December 2015 and Senior Vice President, Chief Accounting Officer from January 2016 to June 2016. In his career, Mr. Carroll served in various financial management positions of increasing responsibility for Genentech, Inc., a member of the Roche Group, Novartis AG and Bristol-Myers Squibb Company. Mr. Carroll is a certified public accountant and received a B.A. in Economics from Ursinus College and an M.B.A. from Rutgers University. Mr. David F. Carroll, also known as Dave, M.B.A. has been Chief Financial Officer and Treasurer at Ophthotech Corporation since April 24, 2017 and served as its Senior Vice President of Finance. Mr. Carroll joined Ophthotech in June 2016 and served as Senior Vice President of Finance from June 2016 to April 2017. Mr. Carroll served in several senior financial leadership roles at The Medicines Company from May 2008 to June 2016, including Vice President and Controller from October 2008 to December 2015 and Senior Vice President, Chief Accounting Officer from January 2016 to June 2016. In his career, Mr. Carroll served in various financial management positions of increasing responsibility for Genentech, Inc., a member of the Roche Group, Novartis AG and Bristol-Myers Squibb Company. Mr. Carroll is a certified public accountant and received a B.A. in Economics from Ursinus College and an M.B.A. from Rutgers University.

Eye Diseases and Disorders